Table 1 Demographics of the 10 patients at baseline
Patient | Gender (F/M) | Age (Years) | Underlying Diseases | #Dialysis History | Co-medication |
|---|---|---|---|---|---|
No. 1 | M | 72 | Diabetes, Hypertension | 3 years | atorvastatin, nifedipine, metoprolol tartrate, caltrate, insulin |
No. 2 | M | 56 | Diabetes, Hypertension, Nephrolithiasis, Coronary heart disease | 4 years | nifedipine, carvedilol, novolin 30R |
No. 3 | F | 56 | Diabetes, Hypertension | 4 years | nifedipine, metoprolol tartrate, carvedilol, novolin 30R |
No. 4 | M | 57 | Nephritis, Hypertension | 4 years | nifedipine, metoprolol tartrate, carvedilol, amlodipine |
No. 5 | F | 54 | Nephritis, Hypertension | 4 years | nifedipine, metoprolol tartrate, carvedilol |
No. 6 | M | 57 | Obstructive Nephropathy, Hydronephrosis, Chronic hepatitis B | 1.5 years | None |
No. 7 | M | 45 | Hydronephrosis | 2 years | metoprolol tartrate, vitamin B12, folic acid |
No. 8 | M | 43 | Nephritis; Hypertension | 1 years | nifedipine, metoprolol tartrate, carvedilol |
No. 9 | F | 27 | Diabetes, Hypertension | 3 years | nifedipine, amlodipine, metoprolol tartrate, caltrate, calcitriol, vitamin B12, folic acid, polysaccharide-iron complex |
No. 10 | M | 25 | Nephritis, Hypertension Coronary heart disease, Chronic Hepatitis B | 2 years | nifedipine, metoprolol tartrate, caltrate |